angiotensin ii has been researched along with temocaprilat in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoka, Y; Aomi, S; Ishizuka, N; Kasanuki, H; Kawana, M; Koyanagi, H; Nagashima, H; Naruse, M; Ogawa, M; Sakomura, Y; Uto, K | 1 |
Asakura, M; Asanuma, H; Funaya, H; Hori, M; Kim, J; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
Itoh, T; Kajikuri, J; Mabuchi, Y; Suzuki, Y; Tada, T | 1 |
1 trial(s) available for angiotensin ii and temocaprilat
Article | Year |
---|---|
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Aortic Diseases; Apoptosis; Cell Count; Cells, Cultured; Culture Media, Serum-Free; Female; Humans; Imidazoles; Indoles; Male; Marfan Syndrome; Middle Aged; Muscle, Smooth, Vascular; Pyridines; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Thiazepines; Tunica Media | 2001 |
2 other study(ies) available for angiotensin ii and temocaprilat
Article | Year |
---|---|
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Coronary Vessels; Dogs; Drug Synergism; Imidazoles; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin; Tetrazoles; Thiazepines; Vasodilation | 2002 |
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cell Membrane Permeability; Cyclic GMP; Enalaprilat; Endothelium, Vascular; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitroarginine; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Thiazepines; Vasodilation | 2003 |